These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10639248)

  • 61. Image-Guided Hydrogen Gas Delivery for Protection from Myocardial Ischemia-Reperfusion Injury via Microbubbles.
    He Y; Zhang B; Chen Y; Jin Q; Wu J; Yan F; Zheng H
    ACS Appl Mater Interfaces; 2017 Jun; 9(25):21190-21199. PubMed ID: 28557412
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel therapeutics in myocardial infarction: targeting microvascular dysfunction and reperfusion injury.
    Fordyce CB; Gersh BJ; Stone GW; Granger CB
    Trends Pharmacol Sci; 2015 Sep; 36(9):605-16. PubMed ID: 26148636
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The anti-inflammatory effects of D-allose contribute to attenuation of cerebral ischemia-reperfusion injury.
    Gao D; Kawai N; Tamiya T
    Med Hypotheses; 2011 Jun; 76(6):911-3. PubMed ID: 21440995
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The pH paradox in ischemia-reperfusion injury to cardiac myocytes.
    Lemasters JJ; Bond JM; Chacon E; Harper IS; Kaplan SH; Ohata H; Trollinger DR; Herman B; Cascio WE
    EXS; 1996; 76():99-114. PubMed ID: 8805791
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oxygen-derived free radicals and myocardial reperfusion injury: an overview.
    Bolli R
    Cardiovasc Drugs Ther; 1991 Mar; 5 Suppl 2():249-68. PubMed ID: 1854667
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants.
    Jeroudi MO; Hartley CJ; Bolli R
    Am J Cardiol; 1994 Mar; 73(6):2B-7B. PubMed ID: 8141076
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Postconditioning with cyclosporine a reduces early renal dysfunction by inhibiting mitochondrial permeability transition.
    Lemoine S; Pillot B; Rognant N; Augeul L; Rayberin M; Varennes A; Laville M; Ovize M; Juillard L
    Transplantation; 2015 Apr; 99(4):717-23. PubMed ID: 25793558
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of myocardial reperfusion injury by ischemic postconditioning requires sirtuin 3-mediated deacetylation of cyclophilin D.
    Bochaton T; Crola-Da-Silva C; Pillot B; Villedieu C; Ferreras L; Alam MR; Thibault H; Strina M; Gharib A; Ovize M; Baetz D
    J Mol Cell Cardiol; 2015 Jul; 84():61-9. PubMed ID: 25871830
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signaling.
    Efthymiou CA; Mocanu MM; Yellon DM
    J Cardiovasc Pharmacol; 2005 Mar; 45(3):247-52. PubMed ID: 15725950
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Induction and Assessment of Ischemia-reperfusion Injury in Langendorff-perfused Rat Hearts.
    Herr DJ; Aune SE; Menick DR
    J Vis Exp; 2015 Jul; (101):e52908. PubMed ID: 26274877
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reperfusion Stimulated Inflammatory Response: Role in Lethal Reperfusion Injury.
    Weber PA; Elliott GT
    J Thromb Thrombolysis; 1997 Jan; 4(1):95-97. PubMed ID: 10639238
    [No Abstract]   [Full Text] [Related]  

  • 72. Differential regulation of apoptosis by ischemia-reperfusion and ischemic adaptation.
    Maulik N; Sasaki H; Galang N
    Ann N Y Acad Sci; 1999 Jun; 874():401-11. PubMed ID: 10415550
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ischemia/Reperfusion Injury following Acute Myocardial Infarction: A Critical Issue for Clinicians and Forensic Pathologists.
    Neri M; Riezzo I; Pascale N; Pomara C; Turillazzi E
    Mediators Inflamm; 2017; 2017():7018393. PubMed ID: 28286377
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Picroside II decreases the development of fibrosis induced by ischemia/reperfusion injury in rats.
    Wang L; Liu XH; Chen H; Chen ZY; Weng XD; Qiu T; Liu L
    Ren Fail; 2014 Oct; 36(9):1443-8. PubMed ID: 25246345
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dyslipidemia in Ischemia/Reperfusion Injury.
    Mazo T; D'Annunzio V; Donato M; Perez V; Zaobornyj T; Gelpi RJ
    Adv Exp Med Biol; 2019; 1127():117-130. PubMed ID: 31140175
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury.
    Argaud L; Gomez L; Gateau-Roesch O; Couture-Lepetit E; Loufouat J; Robert D; Ovize M
    J Mol Cell Cardiol; 2005 Dec; 39(6):893-9. PubMed ID: 16243351
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Remote ischaemic preconditioning: underlying mechanisms and clinical application.
    Hausenloy DJ; Yellon DM
    Cardiovasc Res; 2008 Aug; 79(3):377-86. PubMed ID: 18456674
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The first minutes of reperfusion: a window of opportunity for cardioprotection.
    Piper HM; Abdallah Y; Schäfer C
    Cardiovasc Res; 2004 Feb; 61(3):365-71. PubMed ID: 14962469
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reperfusion injury associated with one-fourth of deaths after coronary artery bypass grafting.
    Weman SM; Karhunen PJ; Penttilä A; Järvinen AA; Salminen US
    Ann Thorac Surg; 2000 Sep; 70(3):807-12. PubMed ID: 11016314
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacokinetics and safety of a single dose of the novel necrosis inhibitor LC28-0126 in healthy male subjects.
    Kim S; Chung H; Lee S; Cho SH; Cho HJ; Kim SH; Jang IJ; Yu KS
    Br J Clin Pharmacol; 2017 Jun; 83(6):1205-1215. PubMed ID: 28002882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.